bibliographic entry 2179151 [be/2179151]
https://w3id.org/oc/corpus/be/2179151

is a

• bibliographic reference

content

• Paul, C, Cather, J, Gooderham, M, Poulin, Y, Mrowietz, U, Ferrandiz, C. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2), Br J Dermatol, 2015, 173, 6, 1387, 1399, DOI: 10.1111/bjd.14164, PMID: 26357944

references

• https://w3id.org/oc/corpus/br/1365207